Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Pulsed electric field treatment may help shrink untreated liver tumors.

Newly made nicotinamide compounds could potentially treat cancer.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Ritlecitinib can help about 14,000 people with severe hair loss.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

MOTILIPERM may help treat male infertility by reducing stress in cells.

Sodium valproate can rarely cause skin darkening, which may improve after stopping the drug.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

Bicalutamide may help treat female pattern hair loss.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The enzyme PST is found in developing human kidneys and helps with detoxification and development.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.